HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1

CUSIP: 44052TAB7

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Debt / NOTE 2.500% 3/1
Market price (% of par)
113.46%
Total 13F principal
$331,544,000
Principal change
-$18,154,000
Total reported market value
$375,896,991
Number of holders
30
Value change
-$18,298,145
Number of buys
18
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 44052TAB7?
CUSIP 44052TAB7 identifies 44052TAB7 - HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 as of Q1 2019

As of 31 Mar 2019, HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 was held by 30 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $331,544,000 in principal (par value) of the bond. The largest 10 bondholders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Allianz Asset Management GmbH, ADVENT CAPITAL MANAGEMENT /DE/, CSS LLC/IL, DLD Asset Management, LP, WELLS FARGO & COMPANY/MN, STATE STREET CORP, Empyrean Capital Partners, LP, MORGAN STANLEY, and SSI INVESTMENT MANAGEMENT INC. This page lists 30 institutional bondholders reporting positions for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.